Schrödinger GmbH

Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for materials design and drug development. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs. Visi…